Thames Ventures VCT 2 Healthcare Shs (TV2H) Competitors

GBX 47.50
0.00 (0.00%)
(As of 05/16/2024 12:51 AM ET)

TV2H vs. KLSO, BPCR, KRM, WCW, ADA, ALGW, WINV, NBDG, TFG, and LFI

Should you be buying Thames Ventures VCT 2 Healthcare Shs stock or one of its competitors? The main competitors of Thames Ventures VCT 2 Healthcare Shs include Kelso Group (KLSO), BioPharma Credit (BPCR), KRM22 (KRM), Walker Crips Group (WCW), Adams (ADA), Alpha Growth (ALGW), Worsley Investors (WINV), NB Distressed Debt New Glb (NBDG), Tetragon Financial (TFG), and London Finance & Investment Group (LFI). These companies are all part of the "asset management" industry.

Thames Ventures VCT 2 Healthcare Shs vs.

Kelso Group (LON:KLSO) and Thames Ventures VCT 2 Healthcare Shs (LON:TV2H) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations.

Kelso Group has higher revenue and earnings than Thames Ventures VCT 2 Healthcare Shs. Thames Ventures VCT 2 Healthcare Shs is trading at a lower price-to-earnings ratio than Kelso Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kelso Group£2.58M4.47£1.53M£0.01307.20
Thames Ventures VCT 2 Healthcare ShsN/AN/AN/A-£0.02-2,375.00

Kelso Group and Thames Ventures VCT 2 Healthcare Shs both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Kelso GroupN/AN/A
Thames Ventures VCT 2 Healthcare ShsN/AN/A

In the previous week, Thames Ventures VCT 2 Healthcare Shs' average media sentiment score of 0.00 equaled Kelso Group'saverage media sentiment score.

Company Overall Sentiment
Kelso Group Neutral
Thames Ventures VCT 2 Healthcare Shs Neutral

Kelso Group has a net margin of 59.53% compared to Kelso Group's net margin of 0.00%. Thames Ventures VCT 2 Healthcare Shs' return on equity of 39.82% beat Kelso Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kelso Group59.53% 39.82% 31.29%
Thames Ventures VCT 2 Healthcare Shs N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kelso Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Thames Ventures VCT 2 Healthcare Shs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

5.8% of Kelso Group shares are owned by institutional investors. 59.9% of Kelso Group shares are owned by insiders. Comparatively, 0.1% of Thames Ventures VCT 2 Healthcare Shs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Kelso Group beats Thames Ventures VCT 2 Healthcare Shs on 8 of the 8 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TV2H vs. The Competition

MetricThames Ventures VCT 2 Healthcare ShsAsset Management IndustryFinancial SectorLON Exchange
Market Cap£11.19M£746.41M£3.00B£1.44B
Dividend Yield2.29%13.28%4.59%11.86%
P/E Ratio-2,375.00917.01471.791,683.95
Price / SalesN/A13,799.022,544.52311,073.16
Price / CashN/A79.7948.2432.94
Price / BookN/A1.751.572.72
Net IncomeN/A£48.62M£382.60M£178.45M
7 Day PerformanceN/A0.77%0.76%1.01%
1 Month PerformanceN/A3.71%3.42%4.25%
1 Year PerformanceN/A5.12%16.42%9.19%

Thames Ventures VCT 2 Healthcare Shs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLSO
Kelso Group
0 of 5 stars
GBX 2.90
+3.2%
N/AN/A£10.89M£2.58M290.00N/APositive News
Gap Down
BPCR
BioPharma Credit
0 of 5 stars
GBX 0.88
-0.2%
N/A-9.1%£10.69M£135.74M10.95N/ANews Coverage
KRM
KRM22
0 of 5 stars
GBX 27.50
flat
N/A-38.9%£9.85M£4.77M-229.1745Gap Down
WCW
Walker Crips Group
0 of 5 stars
GBX 22.50
flat
N/A-15.0%£9.58M£30.87M2,250.00206Dividend Announcement
ADA
Adams
0 of 5 stars
GBX 6.50
flat
N/A-4.8%£9.48M£-2,190,000.00-650.003Gap Down
ALGW
Alpha Growth
0 of 5 stars
GBX 1.90
flat
N/A-9.7%£8.89M£4.64M-7.434Gap Down
WINV
Worsley Investors
0 of 5 stars
GBX 25.20
-1.9%
N/A-20.3%£8.50M£742,000.00840.00N/AGap Up
NBDG
NB Distressed Debt New Glb
0 of 5 stars
GBX 30
flat
N/A-28.6%£8.35MN/A333.33N/AGap Down
High Trading Volume
TFG
Tetragon Financial
0 of 5 stars
GBX 10.20
+1.0%
N/AN/A£8.28M£240.40M6.67N/A
LFI
London Finance & Investment Group
0 of 5 stars
GBX 45.50
-5.0%
N/A+16.7%£14.20M£1.69M1,516.674Gap Down

Related Companies and Tools

This page (LON:TV2H) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners